Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-15

Clinical Trial Update: Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [NA]

View source ↗

Summary

Clinical trial update for metastatic colorectal cancer investigating combination chemotherapy with cetuximab or bevacizumab; the study is terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • Cetuximab (cetuximab)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Metastatic Colorectal Cancer | NA | Status: TERMINATED | Results posted: 2021-03-15